Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication

Completed

Brief Summary: An observational study to collect data from the participants who received urologic surgeries using the Senhance Robotic system.

Detailed Description: This is an observational study and investigators will collect peri-operative demographic data, and short-term outcomes (3-6 months) from the participants who received minimal invasive surgeries using Senhance robotic system in the National Taiwan University Hospital Yunlin Branch, Urology Department. The investigators want to demonstrate if the robotic system is safe and feasible in urologic laparoscopic surgeries.

The operation included TEP, radical prostatectomy, radical nephrectomy (nephroureterectomy) , adrenalectomy, radical cystectomy, and ureter surgery et al.

up to 2022/12, we had recruited 127 TEP, 83 radical prostatectomies, 17 adrenalectomies, 40 nephrectomies, 29 partial nephrectomies, 13 radical cystectomies and 18 other surgeries, such as ureter surgery

Recruitment & Eligibility

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Primary Outcome Measures

Name	Time	Method
Peri-operative complications	postoperative 30 days	Using Clavien-Dindo classification to record the safety outcome
short-term outcome	3-6 months	the short-term outcome was according to a different surgery, such as post-operative 3 months PSA, incontinence rate in radical prostatectomy,

Secondary Outcome Measures

Name	Time	Method

Locations (1): National Taiwan University Hospital
🇨🇳
Taipei, Outside U.S./Canada, Taiwan

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial